From the Desk of Steve Strazza and Alfonso Depablos
The most significant insider transaction on today’s list is a Form 4 filing by Cormorant Asset Management LP.
The hedge fund reported a purchase of $10.4 million in EyePoint Pharmaceuticals Inc $EYPT.